Search Results - "Hibiya, Shuji"

Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease by Takenaka, Kento, Kitazume, Yoshio, Kawamoto, Ami, Fujii, Toshimitsu, Udagawa, Yumi, Wanatabe, Ryosuke, Shimizu, Hiromichi, Hibiya, Shuji, Nagahori, Masakazu, Ohtsuka, Kazuo, Sato, Hiroyuki, Hirakawa, Akihiro, Watanabe, Mamoru, Okamoto, Ryuichi

“…Leucine-rich alpha-2 glycoprotein (LRG) is a newly studied biomarker for inflammatory diseases. This study aimed to investigate whether LRG can be used for…”
Get full text

Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker For Small Bowel Mucosal Activity in Crohn’s Disease by Kawamoto, Ami, Takenaka, Kento, Hibiya, Shuji, Ohtsuka, Kazuo, Okamoto, Ryuichi, Watanabe, Mamoru

“…Active lesions in the small bowel (SB) have been independently associated with poorer prognoses in patients with Crohn’s disease (CD)1; however, there has been…”
Get full text

Establishment of a system to evaluate the therapeutic effect and the dynamics of an investigational drug on ulcerative colitis using human colonic organoids by Nishimura, Ryu, Shirasaki, Tomoaki, Tsuchiya, Kiichiro, Miyake, Yoshihide, Watanabe, Yusuke, Hibiya, Shuji, Watanabe, Sho, Nakamura, Tetsuya, Watanabe, Mamoru

“…Background Ulcerative colitis (UC) is a chronic inflammatory disease of the colon with an intractable, recurrent course. The goal of UC therapy is to target…”
Get full text

Higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease by Takenaka, Kento, Kawamoto, Ami, Hibiya, Shuji, Suzuki, Kohei, Fujii, Toshimitsu, Motobayashi, Maiko, Shimizu, Hiromichi, Nagahori, Masakazu, Saito, Eiko, Okamoto, Ryuichi, Watanabe, Mamoru, Ohtsuka, Kazuo

“…Summary Background Several studies have reported a positive correlation between serum drug concentrations and endoscopic remission in patients with Crohn's…”
Get full text

TP53 Mutation by CRISPR System Enhances the Malignant Potential of Colon Cancer by Watanabe, Sho, Tsuchiya, Kiichiro, Nishimura, Ryu, Shirasaki, Tomoaki, Katsukura, Nobuhiro, Hibiya, Shuji, Okamoto, Ryuichi, Nakamura, Tetsuya, Watanabe, Mamoru

“…Tumor protein p53 (TP53) mutation is a well-known occurrence at the late phase of carcinogenesis during the adenoma-carcinoma sequence of a sporadic colon…”
Get full text

Importance of Telomere Shortening in the Pathogenesis of Ulcerative Colitis: A New Treatment From the Aspect of Telomeres in Intestinal Epithelial Cells by Watanabe, Sho, Hibiya, Shuji, Katsukura, Nobuhiro, Kitagawa, Sayuki, Sato, Ayako, Okamoto, Ryuichi, Watanabe, Mamoru, Tsuchiya, Kiichiro

“…Abstract Background and Aims Ulcerative colitis [UC] is a chronic inflammatory disease of the colon with frequent relapses. Telomere shortening in intestinal…”
Get full text

Transmural Remission Characterized by High Biologic Concentrations Demonstrates Better Prognosis in Crohn’s Disease by Takenaka, Kento, Kawamoto, Ami, Kitazume, Yoshio, Fujii, Toshimitsu, Udagawa, Yumi, Shimizu, Hiromichi, Hibiya, Shuji, Nagahori, Masakazu, Ohtsuka, Kazuo, Watanabe, Mamoru, Okamoto, Ryuichi

“…Abstract Background The importance and pathophysiology of transmural healing in patients with Crohn’s disease [CD] remains to be verified. We aimed to examine…”
Get full text

5‐aminosalicylate–intolerant patients are at increased risk of colectomy for ulcerative colitis by Hibiya, Shuji, Matsuyama, Yusuke, Fujii, Toshimitsu, Maeyashiki, Chiaki, Saito, Eiko, Ito, Kimiko, Shimizu, Hiromichi, Kawamoto, Ami, Motobayashi, Maiko, Takenaka, Kento, Nagahori, Masakazu, Kurosaki, Masayuki, Yauchi, Tsunehito, Ohtsuka, Kazuo, Fujiwara, Takeo, Okamoto, Ryuichi, Watanabe, Mamoru

“…Summary Background Although 5‐aminosalicylate (5‐ASA) is the therapy of first choice in ulcerative colitis (UC), some patients cannot tolerate it because of…”
Get full text

Intestinal phenotype is maintained by Atoh1 in the cancer region of intraductal papillary mucinous neoplasm by Katsukura, Nobuhiro, Watanabe, Sho, Shirasaki, Tomoaki, Hibiya, Shuji, Kano, Yoshihito, Akahoshi, Keiichi, Tanabe, Minoru, Kirimura, Susumu, Akashi, Takumi, Kitagawa, Masanobu, Okamoto, Ryuichi, Watanabe, Mamoru, Tsuchiya, Kiichiro

“…Intraductal papillary mucinous neoplasm (IPMN) is a precancerous lesion of pancreatic cancer. Although there are 4 types of IPMN, among which intestinal‐type…”
Get full text

Schlafen 11 Is a Novel Target for Mucosal Regeneration in Ulcerative Colitis by Watanabe, Sho, Nishimura, Ryu, Shirasaki, Tomoaki, Katsukura, Nobuhiro, Hibiya, Shuji, Kirimura, Susumu, Negi, Mariko, Okamoto, Ryuichi, Matsumoto, Yuka, Nakamura, Tetsuya, Watanabe, Mamoru, Tsuchiya, Kiichiro

“…Abstract Background and Aims Ulcerative colitis [UC] is a chronic inflammatory disease of the colon with an intractable course. Although the goal of UC therapy…”
Get full text

Mucosal healing of small intestinal stricture is associated with improved prognosis post-dilation in Crohn's disease by Hibiya, Shuji, Ohtsuka, Kazuo, Takenaka, Kento, Kawamoto, Ami, Matsuyama, Yusuke, Udagawa, Yumi, Motobayashi, Maiko, Shimizu, Hiromichi, Fujii, Toshimitsu, Saito, Eiko, Nagahori, Masakazu, Okamoto, Ryuichi, Watanabe, Mamoru

“…Small intestinal stricture is a major cause for surgery in Crohn's disease (CD). Endoscopic balloon dilation (EBD) is performed for small intestinal strictures…”
Get full text

Deep neural network for video colonoscopy of ulcerative colitis: a cross-sectional study by Takenaka, Kento, Fujii, Toshimitsu, Kawamoto, Ami, Suzuki, Kohei, Shimizu, Hiromichi, Maeyashiki, Chiaki, Yamaji, Osamu, Motobayashi, Maiko, Igarashi, Akira, Hanazawa, Ryoichi, Hibiya, Shuji, Nagahori, Masakazu, Saito, Eiko, Okamoto, Ryuichi, Ohtsuka, Kazuo, Watanabe, Mamoru

“…A combination of endoscopic and histological evaluation is important in the management of patients with ulcerative colitis. We aimed to adapt our previous deep…”
Get more information

Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn’s disease activity confirmed by balloon-assisted enteroscopy by Kawamoto, Ami, Takenaka, Kento, Hibiya, Shuji, Kitazume, Yoshio, Shimizu, Hiromichi, Fujii, Toshimitsu, Saito, Eiko, Ohtsuka, Kazuo, Okamoto, Ryuichi

“…Background/Aims: Endoscopic activity confirmed by enteroscopy is associated with poor clinical outcome in Crohn’s disease (CD). We investigated which of the…”
Get full text

Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study by Shimizu, Hiromichi, Aonuma, Yuko, Hibiya, Shuji, Kawamoto, Ami, Takenaka, Kento, Fujii, Toshimitsu, Saito, Eiko, Nagahori, Masakazu, Ohtsuka, Kazuo, Okamoto, Ryuichi

“…Background/Aims: The efficacy and safety of tofacitinib for the treatment of refractory ulcerative colitis (UC) has been demonstrated in clinical trials…”
Get full text

Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus by Shimizu, Hiromichi, Fujii, Toshimitsu, Kinoshita, Kenji, Kawamoto, Ami, Hibiya, Shuji, Takenaka, Kento, Saito, Eiko, Nagahori, Masakazu, Ohtsuka, Kazuo, Watanabe, Mamoru, Okamoto, Ryuichi

“…Intravenous corticosteroid is the mainstay for managing acute severe ulcerative colitis, but one-third of patients do not respond to intravenous…”
Get full text

Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab by Fujiwara, Shun, Kawamoto, Ami, Motobayashi, Maiko, Hibiya, Shuji, Takenaka, Kento, Shimizu, Hiromichi, Saito, Eiko, Fujii, Toshimitsu, Nagahori, Masakazu, Kawata, Daisuke, Umezawa, Natsuka, Hosoya, Tadashi, Yasuda, Shinsuke, Ohtsuka, Kazuo, Okamoto, Ryuichi

“…Behcet's disease (BD) is a multisystem immune‐mediated inflammatory disorder that occasionally involves the gastrointestinal tract. Reports on gastrointestinal…”
Get full text

Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis by Shimizu, Hiromichi, Fujii, Toshimitsu, Hibiya, Shuji, Motobayashi, Maiko, Suzuki, Kohei, Takenaka, Kento, Saito, Eiko, Nagahori, Masakazu, Ohtsuka, Kazuo, Watanabe, Mamoru

“…KCI Citation Count: 0…”
Get full text

A case of venous stasis colitis possibly caused by eplerenone by Saito, Eiko, Ohtsuka, Kazuo, Kawamoto, Ami, Fujii, Toshimitsu, Takenaka, Kento, Hibiya, Shuji, Shimizu, Hiromichi, Nagahori, Masakazu, Tomii, Shohei, Okamoto, Ryuichi

“…A 50-year-old man was referred to our hospital for colitis with abdominal pain and diarrhea that had persisted for more than 8 months. 9 months earlier, he had…”
Get full text

Influence of chronic inflammation on the malignant phenotypes and the plasticity of colorectal cancer cells by Watanabe, Sho, Hibiya, Shuji, Katsukura, Nobuhiro, Kitagawa, Sayuki, Sato, Ayako, Okamoto, Ryuichi, Watanabe, Mamoru, Tsuchiya, Kiichiro

“…Sporadic adenoma or adenocarcinoma is often detected during endoscopic surveillance of patients with ulcerative colitis (UC). However, it is occasionally…”
Get full text

Atonal homolog 1 protein stabilized by tumor necrosis factor α induces high malignant potential in colon cancer cell line by Fukushima, Keita, Tsuchiya, Kiichiro, Kano, Yoshihito, Horita, Nobukatsu, Hibiya, Shuji, Hayashi, Ryohei, Kitagaki, Keisuke, Negi, Mariko, Itoh, Eisaku, Akashi, Takumi, Eishi, Yoshinobu, Oshima, Shigeru, Nagaishi, Takashi, Okamoto, Ryuichi, Nakamura, Tetsuya, Watanabe, Mamoru

“…Patients with inflammatory bowel disease (IBD) have an increased risk of developing colitis‐associated colorectal cancer (CAC). CAC cells often develop…”
Get full text